Glykoz
Stage
Seed | AliveTotal Raised
$23.61MLast Raised
$2.25M | 17 yrs agoAbout Glykoz
Developer of anti-infective pharmaceuticals. The company aims to treat disorders such as chronic degenerative diseases, cancer, infections, and immune dysfunction. It has a strategic alliance with Griffith University’s Institute for Glycomics and Monash University’s Department of Microbiology.
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Trusted by the world's smartest companies to:
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Let's see how we can help you!
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Glykoz Frequently Asked Questions (FAQ)
Where is Glykoz's headquarters?
Glykoz's headquarters is located at 15 Chopin Court, Nerang.
What is Glykoz's latest funding round?
Glykoz's latest funding round is Seed.
How much did Glykoz raise?
Glykoz raised a total of $23.61M.
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Trusted by the world's smartest companies to:
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Let's see how we can help you!
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
